Allworth Financial’s Emergent Biosolutions EBS Stock Holding History

Allworth Financial’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.7K	Buy	1,412 +798	+130%	+$8.27K	﹤0.01%	3394
2025 Q4	$7.59K	Buy	614 +165	+37%	+$1.77K	﹤0.01%	3443
2025 Q3	$3.96K	Buy	449 +374	+499%	+$2.91K	﹤0.01%	3682
2025 Q2	$479	Buy	+75	New	+$429	﹤0.01%	4149
2023 Q3	–	Sell	-21	Closed	-$155	–	3467
2023 Q2	$155	Buy	+21	New	+$195	﹤0.01%	3137
2023 Q1	–	Sell	-92	Closed	-$1.09K	–	3227
2022 Q4	$1.09K	Buy	92 +85	+1,214%	+$1.31K	﹤0.01%	2445
2022 Q3	$0	Buy	7 +1	+17%	+$28	﹤0.01%	2768
2022 Q2	$0	Buy	6 +2	+50%	+$68	﹤0.01%	2497
2022 Q1	$0	Sell	4 -191	-98%	-$8.42K	﹤0.01%	2180
2021 Q4	$8K	Buy	+195	New	+$8.82K	﹤0.01%	1463
2021 Q3	–	Sell	-130	Closed	-$8K	–	1895
2021 Q2	$8K	Hold	130	–	–	﹤0.01%	1094
2021 Q1	$12K	Hold	130	–	–	﹤0.01%	930
2020 Q4	$12K	Hold	130	–	–	﹤0.01%	787
2020 Q3	$13K	Hold	130	–	–	﹤0.01%	650
2020 Q2	$10K	Hold	130	–	–	﹤0.01%	723
2020 Q1	$8K	Buy	+130	New	+$7.49K	﹤0.01%	744

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Allworth Financial's EBS Position: Q1 2026 in Review

Allworth Financial increased its Emergent Biosolutions (EBS) stake by 130% in Q1 2026, buying an estimated $8.27K and bringing the position to 1,412 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3394.

Allworth Financial first reported a position in EBS in Q1 2020 and has held it in 16 quarters since. The position peaked at $13K in Q3 2020. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

Allworth Financial held 1,412 shares of Emergent Biosolutions worth $11.7K as of Q1 2026.
Allworth Financial bought 798 Emergent Biosolutions shares in Q1 2026, an estimated $8.27K.
Emergent Biosolutions made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #3394 holding.
Allworth Financial first reported a position in Emergent Biosolutions in Q1 2020 and has held it in 16 quarters since.
Allworth Financial's Emergent Biosolutions position peaked at $13K in Q3 2020.
190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.